Joe and Linda Chlapaty have made a $15 million commitment to Ohio State in the hopes of furthering research into atrial fibrillation, an irregular heartbeat that can lead to stroke, heart failure and other serious complications.
The Chlapatys’ investment will support space within the Interdisciplinary Research Facility, part of Ohio State’s new Innovation District on west campus.
Investments such as this one can have a broad impact on helping facilitate research.
“This generous gift is a remarkable testament to Joe and Linda’s deep commitment to the work we are doing at The Ohio State University Wexner Medical Center,” said Hal Paz, MD, chancellor for health affairs at The Ohio State University. “Philanthropic investments like theirs allow us to bring our many talented researchers together to target life threatening health conditions, like atrial fibrillation, that affect so many in our community.”